Braidwell »

Ironwood Pharmaceuticals shares owned by Braidwell

Quarter-by-quarter ownership of Ironwood Pharmaceuticals shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 16M 1.09
2023-09-30 $15M 16M 0.98

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Ironwood Pharmaceuticals

Wolverine Asset Management
Wellesley Investment Advisors
Balyasny Asset Management
Braidwell
Capstone Investment Advisors
Readystate Asset Management
Calamos Advisors
CSS
Jane Street
Jpmorgan Chase & Co
Shenkman Capital Management
Citigroup
Bank of New York Mellon
D.A. Davidson & Co.
First Hawaiian Bank

View all funds holding Ironwood Pharmaceuticals